Patents for A61L 33 - Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment (5,725)
05/2003
05/14/2003EP1221989B1 Intraluminal device, coating for such device, and method for preparing said device
05/14/2003EP0797459B1 Coating process
05/14/2003CN1418116A 聚磷腈衍生物 Polyphosphazene derivatives
05/14/2003CN1416912A Medical supplementary material producing process
05/13/2003US6562781 Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
05/13/2003US6562362 Copolymer of n-isopropylacrylamide and an ionic strength or pH sensitive monomer; nondegradable; side effects reduction
05/08/2003US20030087024 Measuring thickness of coating on insert surface; ablation exterior surface zone using laser
05/07/2003EP1307432A1 Cyclic oxyguanidine protease inhibitors
05/07/2003EP1307248A2 Bonding spacers to polymeric surfaces
05/06/2003US6559132 Using heparin enriched with respect to high affinity, HA, heparin, coupled to a surface via a carrier molecule for preparing a non-thrombogenic surface for preventing formation of arterial thrombosis
05/06/2003US6558734 Methods for modifying surfaces of articles
05/06/2003CA2197375C Artificial blood vessel
05/02/2003EP1223951A4 Method of preventing adhesions with absorbable polyoxaesters
05/01/2003WO2003035133A1 Stents
05/01/2003WO2002102276A3 Wound dressing and method for controlling severe, life-threatening bleeding
05/01/2003CA2464290A1 Stents
04/2003
04/29/2003US6555587 A reagnet binds to a surface by a latent reactive group and presents an aliphatic acid to a physiological environment in manner sufficient to hold and orient albumin
04/29/2003US6555225 Ion complex, coated product and coating method
04/24/2003US20030078365 Novel polymers for delivering nitric oxide in vivo
04/23/2003EP1303510A2 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/23/2003EP0923390B1 Method for making improved heparinized biomaterials
04/22/2003US6551267 Medical article having blood-contacting surface
04/17/2003WO2003032086A2 Carl for bioelectronics: substrate linkage using a conductive layer
04/17/2003WO2003031533A1 Hydrophilic material and process for producing the same
04/17/2003WO2003030940A1 Method for the surface modification of silicone surfaces
04/17/2003WO2003030879A1 Particle immobilized coatings and uses thereof
04/17/2003WO2003000305A3 Polysaccharide biomaterials and methods of use thereof
04/17/2003US20030073702 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/17/2003US20030072783 Administering nitric oxide adduct to a damaged vascular surface, wherein damaged vascular surface is interior surface of a blood vessel in which damage to endothelium or subendothelium, narrowing or stenosis of vessel has occured
04/15/2003US6547827 Mixing tissue with denaturing agent, surfactant and crosslinking agent
04/10/2003US20030069632 An intravascular stainless steel stent having a tubular wall and a biocompatible coating on at least a major part of the wall surface which coating has a thickness of less than 4mu m and contains a diamond like carbon material
04/10/2003US20030068227 Blood pump and ventricular assist device
04/09/2003CN1408446A Gene carrying rack and its producing method and use
04/09/2003CN1408441A Process for producing freeze-dried human fibrin glue
04/08/2003US6544771 Retroviral gene therapy vectors and therapeutic methods based thereon
04/03/2003WO2003027152A1 Plasma cross-linked hydrophilic coating
04/03/2003WO2003026532A2 Medical devices comprising nanomaterials and therapeutic methods utilizing the same
04/03/2003US20030065379 Reduction of stent thrombogenicity
04/03/2003US20030065377 Coated medical devices
04/03/2003US20030065355 Medical devices comprising nonomaterials and therapeutic methods utilizing the same
04/03/2003US20030065345 Anastomosis devices and methods for treating anastomotic sites
04/02/2003EP1297855A1 Artificial lung of membrane type
04/02/2003EP1296673A1 Antimicrobial coatings
04/02/2003CN1407002A Collagen fibre extracting method and manufacture of tissue filling material therefrom
04/01/2003US6540767 Recoilable thrombosis filtering device and method
03/2003
03/27/2003WO2003024500A1 Treating surfaces to enhance bio-compatibility
03/27/2003WO2003024499A2 Water-soluble coating for bioactive devices
03/27/2003US20030059631 Biocompatible medical articles and process for their production
03/27/2003US20030059620 Block polymer containing polysiloxane and polylactone units;coating medical equipment
03/27/2003US20030059573 Plasma polymerization; pulsed discharges
03/20/2003WO2002096496A8 Embolic devices capable of in-situ reinforcement
03/20/2003US20030055211 Anionic polyelectrolyte; may be mixed with other water soluble anionic polyelectrolyte, especially sodium alginate, to form admixtures or blends from which films, fibers, powders, gels sponges can be prepared
03/19/2003EP1292341A1 Chemically crosslinked material
03/19/2003CN1403169A Systemic anticoagulant heparin material and its prepn
03/18/2003US6534591 First and second polymers containing nucleophilic groups and electrophylic groups capable of reacting to form covalent bonds between polymers, resulting in formation of three-dimensional matrix
03/18/2003US6534510 Anticoagulants
03/18/2003US6533766 Coating medical device surfaces for delivering gas-supersaturated fluids
03/13/2003WO2003020336A2 Stabilizing catheter for protein drug delivery
03/13/2003WO2003020331A1 Implants containing combretastatin a-4
03/13/2003US20030050691 Non-thrombogenic implantable devices
03/13/2003CA2457538A1 Stabilizing catheter for protein drug delivery
03/12/2003EP1018984A4 MEDICAL DEVICE FOR $i(IN VIVO) NITRIC OXIDE RELEASE
03/12/2003EP0642301B1 Pharmaceutically acceptable fixed-dried human blood platelets
03/12/2003CN1401397A Method for mfg. quick dissolving internal supporter for quick vascular anastomosis
03/06/2003US20030045813 Blood gas syringe having improved blood barrier
03/06/2003US20030044596 Biocompatible article
03/05/2003EP1287784A1 Blood gas syringe having improved blood barrier
02/2003
02/27/2003WO2003015677A1 Nitric oxide releasing eptfe coated medical device sandwich
02/27/2003WO2002087472A8 Stent-based delivery of statins to prevent restenosis
02/26/2003EP1285743A1 Latex article
02/26/2003EP1285671A2 Blood pump and ventricular assist device
02/26/2003EP1284780A1 A catheter lock solution including a photo-oxidant
02/26/2003EP0988071B1 Treating metal surfaces to enhance bio-compatibility and/or physical characteristics
02/25/2003US6524322 Anastomosis device
02/20/2003US20030036794 Coated implantable medical device
02/19/2003EP1131112B1 A method for sterilising a medical device having a hydrophilic coating
02/19/2003CN1397354A Porous material for scaffold of tissue engineering and its preparing process
02/18/2003US6521283 Non-thrombogenic surfaces
02/18/2003US6520952 Ceramic reinforced catheter
02/13/2003WO2003011355A1 Endovascular prosthesis coated with a functionalised dextran derivative
02/13/2003WO2003011250A1 Heparin stent
02/12/2003EP1282695A1 Blood-compatible polymer surfaces
02/11/2003US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
02/11/2003US6517858 Bioactive prostheses with immunosuppressive, antistenotic and antithrombotic properties
02/11/2003US6517571 Vascular graft with improved flow surfaces
02/06/2003US20030028244 Coated implantable medical device
02/06/2003US20030028243 Coated implantable medical device
02/06/2003US20030027930 Polymer-matrix materials and methods for making same
02/05/2003EP1280566A2 Growth factor modified protein matrices for tissue engineering
02/05/2003EP1112098B1 Use of a composition comprising heparin as a non-thrombogenic surface coating agent for preventing arterial thrombosis
02/05/2003CN1394902A Sealing article
02/04/2003US6514734 Polybifunctional reagent having a polymeric backbone and latent reactive moieties and bioactive groups
01/2003
01/30/2003WO2003008454A2 Glycoprotein vi fusion proteins
01/30/2003WO2003008011A1 Crosslinked multipolymer coating
01/30/2003WO2003008006A1 Bioactive surface for titanium implants
01/30/2003WO2003007970A2 Use of magnesium for preventing in-stent thrombosis and complications after arterial angioplasty with stent placement
01/30/2003WO2003007687A2 Polymer-matrix materials and methods for making same
01/30/2003US20030021826 Non-thrombogenic semipermeable membrane and method for making same
01/30/2003US20030021762 Polysaccharide biomaterials and methods of use thereof
01/30/2003CA2454043A1 Use of magnesium for preventing in-stent thrombosis and complications after arterial angioplasty with stent placement
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 58